

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.37622341 |
| 2 | central nervous system myelination (GO:0022010) | 5.37622341 |
| 3 | fatty acid elongation (GO:0030497) | 5.01190987 |
| 4 | neuronal action potential propagation (GO:0019227) | 4.01523991 |
| 5 | type I interferon signaling pathway (GO:0060337) | 3.79770707 |
| 6 | cellular response to type I interferon (GO:0071357) | 3.79770707 |
| 7 | response to type I interferon (GO:0034340) | 3.76824091 |
| 8 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.69253818 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 3.59581357 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.59581357 |
| 11 | negative regulation of neurotransmitter transport (GO:0051589) | 3.52664461 |
| 12 | response to peptidoglycan (GO:0032494) | 3.51469064 |
| 13 | neuromuscular process controlling posture (GO:0050884) | 3.43366424 |
| 14 | iron coordination entity transport (GO:1901678) | 3.41239662 |
| 15 | regulation of T cell tolerance induction (GO:0002664) | 3.40715226 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 3.39987498 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 3.37369520 |
| 18 | negative regulation of interleukin-8 production (GO:0032717) | 3.35012104 |
| 19 | heme transport (GO:0015886) | 3.32697512 |
| 20 | regulation of tolerance induction (GO:0002643) | 3.31626663 |
| 21 | gamma-aminobutyric acid transport (GO:0015812) | 3.26326053 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 3.25234848 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.25234848 |
| 24 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.25197358 |
| 25 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.22004014 |
| 26 | axon ensheathment (GO:0008366) | 3.19153972 |
| 27 | ensheathment of neurons (GO:0007272) | 3.19153972 |
| 28 | myelination (GO:0042552) | 3.17660552 |
| 29 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.15895895 |
| 30 | cerebellar granule cell differentiation (GO:0021707) | 3.14384617 |
| 31 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.12256232 |
| 32 | L-amino acid import (GO:0043092) | 3.09739658 |
| 33 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.09638415 |
| 34 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.07149419 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.06786765 |
| 36 | cholesterol biosynthetic process (GO:0006695) | 3.06353618 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.03588470 |
| 38 | neurotransmitter catabolic process (GO:0042135) | 3.03470457 |
| 39 | creatine metabolic process (GO:0006600) | 2.97990193 |
| 40 | glycerophospholipid catabolic process (GO:0046475) | 2.94944180 |
| 41 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92048987 |
| 42 | locomotory exploration behavior (GO:0035641) | 2.91273414 |
| 43 | glutamate secretion (GO:0014047) | 2.90165437 |
| 44 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.90083595 |
| 45 | glutamate receptor signaling pathway (GO:0007215) | 2.89287890 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.88112218 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.87535012 |
| 48 | adult walking behavior (GO:0007628) | 2.86457812 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 2.85197735 |
| 50 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.83809091 |
| 51 | glycosphingolipid catabolic process (GO:0046479) | 2.82301918 |
| 52 | angiotensin maturation (GO:0002003) | 2.81165964 |
| 53 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.80887497 |
| 54 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.80568195 |
| 55 | cellular response to exogenous dsRNA (GO:0071360) | 2.80408443 |
| 56 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.79663359 |
| 57 | presynaptic membrane organization (GO:0097090) | 2.79555589 |
| 58 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.78009857 |
| 59 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.77765091 |
| 60 | regulation of interferon-alpha production (GO:0032647) | 2.76351690 |
| 61 | transmission of nerve impulse (GO:0019226) | 2.74614994 |
| 62 | presynaptic membrane assembly (GO:0097105) | 2.73717629 |
| 63 | cellular response to ethanol (GO:0071361) | 2.73400979 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 2.71744758 |
| 65 | regulation of synaptic vesicle transport (GO:1902803) | 2.71309740 |
| 66 | regulation of collateral sprouting (GO:0048670) | 2.70868414 |
| 67 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.70850876 |
| 68 | sterol biosynthetic process (GO:0016126) | 2.70741850 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 2.69893648 |
| 70 | interferon-gamma secretion (GO:0072643) | 2.69001699 |
| 71 | positive regulation by symbiont of host defense response (GO:0052509) | 2.68758685 |
| 72 | modulation by symbiont of host defense response (GO:0052031) | 2.68758685 |
| 73 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.68758685 |
| 74 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.68758685 |
| 75 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.68758685 |
| 76 | modulation by symbiont of host immune response (GO:0052553) | 2.68758685 |
| 77 | glycosylceramide metabolic process (GO:0006677) | 2.68461250 |
| 78 | establishment of mitochondrion localization (GO:0051654) | 2.68038525 |
| 79 | glycolipid catabolic process (GO:0019377) | 2.66210883 |
| 80 | synaptic vesicle maturation (GO:0016188) | 2.65130848 |
| 81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65068015 |
| 82 | positive regulation of type 2 immune response (GO:0002830) | 2.64780453 |
| 83 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.64491821 |
| 84 | germinal center formation (GO:0002467) | 2.64044903 |
| 85 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.64030174 |
| 86 | cellular potassium ion homeostasis (GO:0030007) | 2.63696124 |
| 87 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.62929564 |
| 88 | thioester biosynthetic process (GO:0035384) | 2.62661114 |
| 89 | acyl-CoA biosynthetic process (GO:0071616) | 2.62661114 |
| 90 | neurotransmitter secretion (GO:0007269) | 2.61687486 |
| 91 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.61051646 |
| 92 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.61051646 |
| 93 | mating behavior (GO:0007617) | 2.60174911 |
| 94 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.60166342 |
| 95 | neuron-neuron synaptic transmission (GO:0007270) | 2.59152567 |
| 96 | response to protozoan (GO:0001562) | 2.58804626 |
| 97 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.58653003 |
| 98 | response to methylmercury (GO:0051597) | 2.58017612 |
| 99 | vocalization behavior (GO:0071625) | 2.57934657 |
| 100 | acidic amino acid transport (GO:0015800) | 2.57436042 |
| 101 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.57371877 |
| 102 | L-glutamate transport (GO:0015813) | 2.57166496 |
| 103 | very long-chain fatty acid metabolic process (GO:0000038) | 2.55172056 |
| 104 | peptide catabolic process (GO:0043171) | 2.54451745 |
| 105 | T cell migration (GO:0072678) | 2.54434061 |
| 106 | regulation of beta-amyloid formation (GO:1902003) | 2.54207200 |
| 107 | potassium ion import (GO:0010107) | 2.52171921 |
| 108 | behavioral response to cocaine (GO:0048148) | 2.51676473 |
| 109 | neurotransmitter transport (GO:0006836) | 2.50702335 |
| 110 | myelin maintenance (GO:0043217) | 2.50126246 |
| 111 | C4-dicarboxylate transport (GO:0015740) | 2.49949691 |
| 112 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.49468060 |
| 113 | synaptic transmission, glutamatergic (GO:0035249) | 2.49148740 |
| 114 | long-term memory (GO:0007616) | 2.48616688 |
| 115 | transferrin transport (GO:0033572) | 2.48560600 |
| 116 | negative regulation of protein localization to cell surface (GO:2000009) | 2.47800302 |
| 117 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.46061308 |
| 118 | neurotransmitter uptake (GO:0001504) | 2.45235115 |
| 119 | detection of molecule of bacterial origin (GO:0032490) | 2.44367445 |
| 120 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.43535820 |
| 121 | glutathione biosynthetic process (GO:0006750) | 2.43063126 |
| 122 | defense response to protozoan (GO:0042832) | 2.42412202 |
| 123 | regulation of neurotransmitter levels (GO:0001505) | 2.41339825 |
| 124 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.41213964 |
| 125 | regulation of type 2 immune response (GO:0002828) | 2.41039150 |
| 126 | myeloid dendritic cell differentiation (GO:0043011) | 2.41007591 |
| 127 | positive regulation of leukocyte degranulation (GO:0043302) | 2.40258624 |
| 128 | apical protein localization (GO:0045176) | 2.40077109 |
| 129 | substantia nigra development (GO:0021762) | 2.39129203 |
| 130 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.38190749 |
| 131 | ER overload response (GO:0006983) | 2.37982488 |
| 132 | iron ion import (GO:0097286) | 2.36701612 |
| 133 | amino acid import (GO:0043090) | 2.36633443 |
| 134 | long-term synaptic potentiation (GO:0060291) | 2.36191873 |
| 135 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.35374979 |
| 136 | regulation of necroptotic process (GO:0060544) | 2.34746567 |
| 137 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.32728919 |
| 138 | response to host immune response (GO:0052572) | 2.32728919 |
| 139 | trivalent inorganic cation transport (GO:0072512) | 2.32569746 |
| 140 | ferric iron transport (GO:0015682) | 2.32569746 |
| 141 | regulation of synapse structural plasticity (GO:0051823) | 2.32508878 |
| 142 | detection of other organism (GO:0098543) | 2.32337136 |
| 143 | B cell receptor signaling pathway (GO:0050853) | 2.32121307 |
| 144 | aromatic amino acid family catabolic process (GO:0009074) | 2.31727386 |
| 145 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.31651951 |
| 146 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.31351443 |
| 147 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.31311113 |
| 148 | neuron remodeling (GO:0016322) | 2.31285964 |
| 149 | negative regulation of synaptic transmission (GO:0050805) | 2.29129807 |
| 150 | regulation of leukocyte degranulation (GO:0043300) | 2.28961857 |
| 151 | negative regulation of macroautophagy (GO:0016242) | 2.28447309 |
| 152 | protein targeting to lysosome (GO:0006622) | 2.27846698 |
| 153 | establishment of protein localization to vacuole (GO:0072666) | 2.27846698 |
| 154 | protein targeting to vacuole (GO:0006623) | 2.27846698 |
| 155 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.27828283 |
| 156 | positive regulation of membrane potential (GO:0045838) | 2.27211627 |
| 157 | coenzyme catabolic process (GO:0009109) | 2.26988270 |
| 158 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.26686390 |
| 159 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.26126293 |
| 160 | autophagic vacuole fusion (GO:0000046) | 2.25951297 |
| 161 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.25765142 |
| 162 | carnitine transmembrane transport (GO:1902603) | 2.25760907 |
| 163 | regulation of mast cell degranulation (GO:0043304) | 2.25284459 |
| 164 | T-helper 1 type immune response (GO:0042088) | 2.25243208 |
| 165 | negative regulation of type 2 immune response (GO:0002829) | 2.25118683 |
| 166 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.24670621 |
| 167 | regulation of chemokine biosynthetic process (GO:0045073) | 2.24635922 |
| 168 | mature B cell differentiation involved in immune response (GO:0002313) | 2.24443704 |
| 169 | mature B cell differentiation (GO:0002335) | 2.23980398 |
| 170 | regulation of vitamin metabolic process (GO:0030656) | 2.23416150 |
| 171 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.23270560 |
| 172 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.22829856 |
| 173 | cellular extravasation (GO:0045123) | 2.22120072 |
| 174 | neutrophil activation involved in immune response (GO:0002283) | 2.21391062 |
| 175 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.21075640 |
| 176 | response to host (GO:0075136) | 2.20171205 |
| 177 | response to host defenses (GO:0052200) | 2.20171205 |
| 178 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.20171205 |
| 179 | detection of bacterium (GO:0016045) | 2.20167432 |
| 180 | cellular response to interferon-gamma (GO:0071346) | 2.19675527 |
| 181 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.18993693 |
| 182 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.18774778 |
| 183 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.18754690 |
| 184 | oligosaccharide catabolic process (GO:0009313) | 2.18579330 |
| 185 | cellular response to interferon-alpha (GO:0035457) | 2.18448692 |
| 186 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.17819479 |
| 187 | ceramide catabolic process (GO:0046514) | 2.16161653 |
| 188 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.15933757 |
| 189 | detection of external biotic stimulus (GO:0098581) | 2.15885539 |
| 190 | macroautophagy (GO:0016236) | 2.15569777 |
| 191 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.15355317 |
| 192 | carnitine transport (GO:0015879) | 2.15303291 |
| 193 | amino-acid betaine transport (GO:0015838) | 2.15303291 |
| 194 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.15234668 |
| 195 | dendritic cell differentiation (GO:0097028) | 2.14761170 |
| 196 | sphingosine metabolic process (GO:0006670) | 2.14632066 |
| 197 | hepatocyte apoptotic process (GO:0097284) | 2.13173640 |
| 198 | negative regulation of humoral immune response (GO:0002921) | 2.10812507 |
| 199 | regulation of necrotic cell death (GO:0010939) | 2.10138862 |
| 200 | NIK/NF-kappaB signaling (GO:0038061) | 2.09611674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.32216088 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.87810987 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.27375551 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.12461327 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.94515621 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.91858496 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.68238107 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60411184 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.58831563 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.52999565 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51385359 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.46997908 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.45913703 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42599182 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.34303902 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32621745 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32410230 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.32243576 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.22502581 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21840258 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.20750021 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19276716 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17758158 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17198110 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.17128903 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13574211 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.09901181 |
| 28 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.07225526 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.99527205 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98547626 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90918002 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88103313 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.87191457 |
| 34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.80316851 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79161750 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.76418035 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75482052 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75156187 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73710189 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71996183 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.70330237 |
| 42 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68734278 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.67530639 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.67530639 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65665196 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64533786 |
| 47 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.62723157 |
| 48 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61753929 |
| 49 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.60343996 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59204264 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57801437 |
| 52 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.57669277 |
| 53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56414196 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55557879 |
| 55 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54030973 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53949895 |
| 57 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52943412 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51783768 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49072616 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48915585 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47960567 |
| 62 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47729111 |
| 63 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47433308 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47386972 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46758084 |
| 66 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46085352 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45543920 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45166644 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43228270 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42448445 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42295688 |
| 72 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.41881420 |
| 73 | MYB_26560356_Chip-Seq_TH2_Human | 1.40600145 |
| 74 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39103795 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37259171 |
| 76 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36616580 |
| 77 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36138503 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35172556 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.34024919 |
| 80 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33676815 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33339736 |
| 82 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32658831 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32488213 |
| 84 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30549166 |
| 85 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.30462882 |
| 86 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30444591 |
| 87 | MYB_26560356_Chip-Seq_TH1_Human | 1.29779178 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29339204 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28902551 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27920726 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27792115 |
| 92 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27548304 |
| 93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.27492478 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24969300 |
| 95 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24758105 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24714852 |
| 97 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24560275 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24416441 |
| 99 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24091692 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23689326 |
| 101 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23426277 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23351200 |
| 103 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22570023 |
| 104 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22361145 |
| 105 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.22022115 |
| 106 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21638139 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19445616 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18295492 |
| 109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18295492 |
| 110 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.18286315 |
| 111 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17444501 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15692287 |
| 113 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15161919 |
| 114 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14822662 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14288312 |
| 116 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14145648 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13379249 |
| 118 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12497097 |
| 119 | MAF_26560356_Chip-Seq_TH1_Human | 1.11738686 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11669459 |
| 121 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11538262 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11222667 |
| 123 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10959373 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09941973 |
| 125 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.08680618 |
| 126 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08021501 |
| 127 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07405671 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07307482 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07067179 |
| 130 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05936145 |
| 131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05524024 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05239021 |
| 133 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05183289 |
| 134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04920392 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04567525 |
| 136 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03809149 |
| 137 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03524074 |
| 138 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02545671 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02340558 |
| 140 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02249924 |
| 141 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01698613 |
| 142 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01366470 |
| 143 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00933918 |
| 144 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00828615 |
| 145 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00508842 |
| 146 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00115664 |
| 147 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00114588 |
| 148 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00022803 |
| 149 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99557285 |
| 150 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98423480 |
| 151 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96591807 |
| 152 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96509548 |
| 153 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96254046 |
| 154 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95399112 |
| 155 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94729993 |
| 156 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94724753 |
| 157 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93907915 |
| 158 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93761996 |
| 159 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93087414 |
| 160 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92962222 |
| 161 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92718072 |
| 162 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92697011 |
| 163 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92697011 |
| 164 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92466799 |
| 165 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92466799 |
| 166 | MAF_26560356_Chip-Seq_TH2_Human | 0.91722538 |
| 167 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90942861 |
| 168 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88950007 |
| 169 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88628111 |
| 170 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.87352303 |
| 171 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86579520 |
| 172 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86123375 |
| 173 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.86026948 |
| 174 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84933042 |
| 175 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84529983 |
| 176 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.83658033 |
| 177 | JUN_21703547_ChIP-Seq_K562_Human | 0.83596754 |
| 178 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.83373473 |
| 179 | KDM2B_26808549_Chip-Seq_REH_Human | 0.82905943 |
| 180 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82342657 |
| 181 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82054251 |
| 182 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81901559 |
| 183 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81899841 |
| 184 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.81680989 |
| 185 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81256581 |
| 186 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79952408 |
| 187 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.79343006 |
| 188 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79129440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.03832215 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.74523038 |
| 3 | MP0003329_amyloid_beta_deposits | 3.52840808 |
| 4 | MP0003303_peritoneal_inflammation | 3.43748341 |
| 5 | MP0004270_analgesia | 3.22514771 |
| 6 | MP0000920_abnormal_myelination | 2.97320106 |
| 7 | MP0009046_muscle_twitch | 2.93464776 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.89835925 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.88912026 |
| 10 | MP0006082_CNS_inflammation | 2.85245182 |
| 11 | MP0002064_seizures | 2.76842389 |
| 12 | MP0009840_abnormal_foam_cell | 2.76806512 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.73054428 |
| 14 | MP0003195_calcinosis | 2.62647831 |
| 15 | MP0002272_abnormal_nervous_system | 2.51498816 |
| 16 | MP0009785_altered_susceptibility_to | 2.41697742 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.41098672 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.40524204 |
| 19 | MP0009745_abnormal_behavioral_response | 2.36598709 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.35610717 |
| 21 | MP0003724_increased_susceptibility_to | 2.26819055 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.20796083 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.19202339 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.18837407 |
| 25 | MP0005387_immune_system_phenotype | 2.16697032 |
| 26 | MP0001790_abnormal_immune_system | 2.16697032 |
| 27 | MP0000604_amyloidosis | 2.15273686 |
| 28 | MP0001440_abnormal_grooming_behavior | 2.13311836 |
| 29 | MP0003436_decreased_susceptibility_to | 2.11173127 |
| 30 | MP0004043_abnormal_pH_regulation | 2.11102808 |
| 31 | MP0005025_abnormal_response_to | 2.04931985 |
| 32 | MP0002063_abnormal_learning/memory/cond | 2.04849529 |
| 33 | MP0003690_abnormal_glial_cell | 2.04413378 |
| 34 | MP0003300_gastrointestinal_ulcer | 2.02130475 |
| 35 | MP0001501_abnormal_sleep_pattern | 2.01164986 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.96838776 |
| 37 | MP0001486_abnormal_startle_reflex | 1.96051054 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.95913161 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.94238138 |
| 40 | MP0002419_abnormal_innate_immunity | 1.93663640 |
| 41 | MP0001800_abnormal_humoral_immune | 1.91633775 |
| 42 | MP0004142_abnormal_muscle_tone | 1.91390339 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.81578956 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.80441501 |
| 45 | MP0004264_abnormal_extraembryonic_tissu | 1.80278462 |
| 46 | MP0000685_abnormal_immune_system | 1.78154049 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.77866207 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.76229985 |
| 49 | MP0001905_abnormal_dopamine_level | 1.74711819 |
| 50 | MP0001529_abnormal_vocalization | 1.74086709 |
| 51 | MP0002723_abnormal_immune_serum | 1.69271610 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.66891288 |
| 53 | MP0008569_lethality_at_weaning | 1.65277889 |
| 54 | MP0002735_abnormal_chemical_nociception | 1.64476762 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.64288496 |
| 56 | MP0005332_abnormal_amino_acid | 1.64103694 |
| 57 | MP0005360_urolithiasis | 1.64055210 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.63933687 |
| 59 | MP0008260_abnormal_autophagy | 1.59791081 |
| 60 | MP0001970_abnormal_pain_threshold | 1.59454617 |
| 61 | MP0003632_abnormal_nervous_system | 1.57483556 |
| 62 | MP0005365_abnormal_bile_salt | 1.56427757 |
| 63 | MP0004885_abnormal_endolymph | 1.55885436 |
| 64 | MP0005451_abnormal_body_composition | 1.55878132 |
| 65 | MP0004924_abnormal_behavior | 1.55469853 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.55469853 |
| 67 | MP0002822_catalepsy | 1.55241480 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.54779653 |
| 69 | MP0003634_abnormal_glial_cell | 1.54512404 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.52967876 |
| 71 | MP0002229_neurodegeneration | 1.52556375 |
| 72 | MP0005671_abnormal_response_to | 1.52302374 |
| 73 | MP0001819_abnormal_immune_cell | 1.52060462 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.51670684 |
| 75 | MP0001873_stomach_inflammation | 1.50958175 |
| 76 | MP0002736_abnormal_nociception_after | 1.50752014 |
| 77 | MP0005085_abnormal_gallbladder_physiolo | 1.50248705 |
| 78 | MP0004742_abnormal_vestibular_system | 1.45612369 |
| 79 | MP0002733_abnormal_thermal_nociception | 1.42754452 |
| 80 | MP0008469_abnormal_protein_level | 1.41744770 |
| 81 | MP0003763_abnormal_thymus_physiology | 1.38769704 |
| 82 | MP0005166_decreased_susceptibility_to | 1.37476523 |
| 83 | MP0002876_abnormal_thyroid_physiology | 1.36508895 |
| 84 | MP0005083_abnormal_biliary_tract | 1.36081355 |
| 85 | MP0003631_nervous_system_phenotype | 1.35551939 |
| 86 | MP0004947_skin_inflammation | 1.34604807 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 1.34372363 |
| 88 | MP0002405_respiratory_system_inflammati | 1.29860862 |
| 89 | MP0009764_decreased_sensitivity_to | 1.29532476 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.28839606 |
| 91 | MP0003633_abnormal_nervous_system | 1.27495955 |
| 92 | MP0003075_altered_response_to | 1.25531979 |
| 93 | MP0003950_abnormal_plasma_membrane | 1.24188526 |
| 94 | MP0002166_altered_tumor_susceptibility | 1.23804725 |
| 95 | MP0009333_abnormal_splenocyte_physiolog | 1.19956487 |
| 96 | MP0000778_abnormal_nervous_system | 1.19642600 |
| 97 | MP0003879_abnormal_hair_cell | 1.18354533 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 1.17572137 |
| 99 | MP0008004_abnormal_stomach_pH | 1.16185609 |
| 100 | MP0000955_abnormal_spinal_cord | 1.16071877 |
| 101 | MP0002184_abnormal_innervation | 1.16063412 |
| 102 | MP0001666_abnormal_nutrient_absorption | 1.15902721 |
| 103 | MP0000013_abnormal_adipose_tissue | 1.15628592 |
| 104 | MP0001533_abnormal_skeleton_physiology | 1.15027811 |
| 105 | MP0000716_abnormal_immune_system | 1.12119654 |
| 106 | MP0004510_myositis | 1.10891407 |
| 107 | MP0003252_abnormal_bile_duct | 1.09976819 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 1.09097367 |
| 109 | MP0005164_abnormal_response_to | 1.06763621 |
| 110 | MP0001661_extended_life_span | 1.04480825 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 1.03873175 |
| 112 | MP0005535_abnormal_body_temperature | 1.02780423 |
| 113 | MP0003045_fibrosis | 1.02592663 |
| 114 | MP0002332_abnormal_exercise_endurance | 1.02246334 |
| 115 | MP0002882_abnormal_neuron_morphology | 1.02155296 |
| 116 | MP0004381_abnormal_hair_follicle | 1.02098850 |
| 117 | MP0000609_abnormal_liver_physiology | 1.01306915 |
| 118 | MP0009643_abnormal_urine_homeostasis | 1.00731007 |
| 119 | MP0003866_abnormal_defecation | 0.99808557 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.98849651 |
| 121 | MP0005645_abnormal_hypothalamus_physiol | 0.98734497 |
| 122 | MP0010678_abnormal_skin_adnexa | 0.98655889 |
| 123 | MP0002132_abnormal_respiratory_system | 0.98385594 |
| 124 | MP0010329_abnormal_lipoprotein_level | 0.97800150 |
| 125 | MP0006276_abnormal_autonomic_nervous | 0.97607949 |
| 126 | MP0002998_abnormal_bone_remodeling | 0.97460396 |
| 127 | MP0002090_abnormal_vision | 0.96639641 |
| 128 | MP0008872_abnormal_physiological_respon | 0.96420938 |
| 129 | MP0001986_abnormal_taste_sensitivity | 0.95104583 |
| 130 | MP0002398_abnormal_bone_marrow | 0.94452634 |
| 131 | MP0004019_abnormal_vitamin_homeostasis | 0.93770433 |
| 132 | MP0005397_hematopoietic_system_phenotyp | 0.93592521 |
| 133 | MP0001545_abnormal_hematopoietic_system | 0.93592521 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.93525322 |
| 135 | MP0002557_abnormal_social/conspecific_i | 0.92551979 |
| 136 | MP0002877_abnormal_melanocyte_morpholog | 0.90259568 |
| 137 | MP0000747_muscle_weakness | 0.90190206 |
| 138 | MP0001765_abnormal_ion_homeostasis | 0.89541014 |
| 139 | MP0000343_altered_response_to | 0.89427989 |
| 140 | MP0001502_abnormal_circadian_rhythm | 0.89158670 |
| 141 | MP0000858_altered_metastatic_potential | 0.88648849 |
| 142 | MP0004811_abnormal_neuron_physiology | 0.88457587 |
| 143 | MP0005310_abnormal_salivary_gland | 0.88430578 |
| 144 | MP0002006_tumorigenesis | 0.87148889 |
| 145 | MP0002429_abnormal_blood_cell | 0.84559408 |
| 146 | MP0004883_abnormal_blood_vessel | 0.84290666 |
| 147 | MP0001663_abnormal_digestive_system | 0.83625505 |
| 148 | MP0000647_abnormal_sebaceous_gland | 0.83442597 |
| 149 | MP0002909_abnormal_adrenal_gland | 0.83412751 |
| 150 | MP0009763_increased_sensitivity_to | 0.83207111 |
| 151 | MP0003091_abnormal_cell_migration | 0.82719767 |
| 152 | MP0004145_abnormal_muscle_electrophysio | 0.81613653 |
| 153 | MP0001177_atelectasis | 0.81522853 |
| 154 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81107077 |
| 155 | MP0003868_abnormal_feces_composition | 0.79633264 |
| 156 | MP0002136_abnormal_kidney_physiology | 0.76881974 |
| 157 | MP0005666_abnormal_adipose_tissue | 0.76664424 |
| 158 | MP0002971_abnormal_brown_adipose | 0.76226999 |
| 159 | MP0005165_increased_susceptibility_to | 0.75482470 |
| 160 | MP0002069_abnormal_eating/drinking_beha | 0.74643846 |
| 161 | MP0000249_abnormal_blood_vessel | 0.74369134 |
| 162 | MP0001963_abnormal_hearing_physiology | 0.71237640 |
| 163 | MP0009780_abnormal_chondrocyte_physiolo | 0.71076811 |
| 164 | MP0009115_abnormal_fat_cell | 0.70492279 |
| 165 | MP0000689_abnormal_spleen_morphology | 0.69975624 |
| 166 | MP0008874_decreased_physiological_sensi | 0.69783415 |
| 167 | MP0000383_abnormal_hair_follicle | 0.69599050 |
| 168 | MP0003806_abnormal_nucleotide_metabolis | 0.69108957 |
| 169 | MP0002722_abnormal_immune_system | 0.69050295 |
| 170 | MP0000579_abnormal_nail_morphology | 0.68640242 |
| 171 | MP0001664_abnormal_digestion | 0.68163620 |
| 172 | MP0001984_abnormal_olfaction | 0.68135952 |
| 173 | MP0001756_abnormal_urination | 0.65311403 |
| 174 | MP0001485_abnormal_pinna_reflex | 0.64699288 |
| 175 | MP0002152_abnormal_brain_morphology | 0.62081570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.16095693 |
| 2 | Focal motor seizures (HP:0011153) | 4.26749680 |
| 3 | Cerebral inclusion bodies (HP:0100314) | 4.09440985 |
| 4 | Supranuclear gaze palsy (HP:0000605) | 3.72779151 |
| 5 | Myokymia (HP:0002411) | 3.60151390 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.50210545 |
| 7 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.40551358 |
| 8 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.40551358 |
| 9 | Dysostosis multiplex (HP:0000943) | 3.40057526 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.30845284 |
| 11 | Mucopolysacchariduria (HP:0008155) | 3.30845284 |
| 12 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.27025037 |
| 13 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.27025037 |
| 14 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.27025037 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.26614950 |
| 16 | Abnormality of the corticospinal tract (HP:0002492) | 3.25304672 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.22108986 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.15510102 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.13323858 |
| 20 | Focal seizures (HP:0007359) | 3.12395743 |
| 21 | Atonic seizures (HP:0010819) | 3.11565356 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.06342674 |
| 23 | Dysmetria (HP:0001310) | 3.04615337 |
| 24 | Dialeptic seizures (HP:0011146) | 3.01668659 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.01091746 |
| 26 | Colitis (HP:0002583) | 2.99183242 |
| 27 | Intention tremor (HP:0002080) | 2.97797835 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.97524662 |
| 29 | Recurrent abscess formation (HP:0002722) | 2.97506545 |
| 30 | Absence seizures (HP:0002121) | 2.88751555 |
| 31 | Pheochromocytoma (HP:0002666) | 2.87323096 |
| 32 | Orchitis (HP:0100796) | 2.85905345 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85407723 |
| 34 | Myositis (HP:0100614) | 2.85357237 |
| 35 | Cerebral hemorrhage (HP:0001342) | 2.84224791 |
| 36 | Action tremor (HP:0002345) | 2.83417047 |
| 37 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.78195946 |
| 38 | Scanning speech (HP:0002168) | 2.75014959 |
| 39 | Optic neuritis (HP:0100653) | 2.73521910 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.73521910 |
| 41 | Loss of speech (HP:0002371) | 2.71534884 |
| 42 | Visual hallucinations (HP:0002367) | 2.70782338 |
| 43 | Spastic gait (HP:0002064) | 2.69510332 |
| 44 | Spastic paraparesis (HP:0002313) | 2.68976528 |
| 45 | Conjugated hyperbilirubinemia (HP:0002908) | 2.67648783 |
| 46 | Epileptic encephalopathy (HP:0200134) | 2.66452778 |
| 47 | Neuroendocrine neoplasm (HP:0100634) | 2.66165745 |
| 48 | Malnutrition (HP:0004395) | 2.64429995 |
| 49 | Generalized tonic-clonic seizures (HP:0002069) | 2.63782659 |
| 50 | Lower limb hyperreflexia (HP:0002395) | 2.62956770 |
| 51 | Vasculitis (HP:0002633) | 2.62034764 |
| 52 | Insidious onset (HP:0003587) | 2.60782760 |
| 53 | Termporal pattern (HP:0011008) | 2.60782760 |
| 54 | Spastic tetraparesis (HP:0001285) | 2.60294422 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.57473450 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.54883856 |
| 57 | Hyperventilation (HP:0002883) | 2.54763156 |
| 58 | Parakeratosis (HP:0001036) | 2.53845074 |
| 59 | Progressive cerebellar ataxia (HP:0002073) | 2.53566365 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53323399 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53323399 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53323399 |
| 63 | Retinal dysplasia (HP:0007973) | 2.50956454 |
| 64 | Progressive inability to walk (HP:0002505) | 2.50290532 |
| 65 | Recurrent viral infections (HP:0004429) | 2.50030129 |
| 66 | Akinesia (HP:0002304) | 2.49484066 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46689117 |
| 68 | Xanthomatosis (HP:0000991) | 2.45664989 |
| 69 | Intrahepatic cholestasis (HP:0001406) | 2.44942673 |
| 70 | Increased serum ferritin (HP:0003281) | 2.44420865 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.41790837 |
| 72 | Split foot (HP:0001839) | 2.38147540 |
| 73 | Ankle clonus (HP:0011448) | 2.38031141 |
| 74 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36589046 |
| 75 | Gout (HP:0001997) | 2.35599416 |
| 76 | Hyperglycinemia (HP:0002154) | 2.35307956 |
| 77 | Glomerulonephritis (HP:0000099) | 2.35295802 |
| 78 | Chronic diarrhea (HP:0002028) | 2.34778155 |
| 79 | Cerebral hypomyelination (HP:0006808) | 2.32978192 |
| 80 | Recurrent bronchitis (HP:0002837) | 2.31809148 |
| 81 | Hemorrhage of the eye (HP:0011885) | 2.30413169 |
| 82 | Onion bulb formation (HP:0003383) | 2.26995012 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.23439215 |
| 84 | Fat malabsorption (HP:0002630) | 2.22750546 |
| 85 | Peripheral hypomyelination (HP:0007182) | 2.21109830 |
| 86 | Recurrent sinusitis (HP:0011108) | 2.21047080 |
| 87 | Recurrent skin infections (HP:0001581) | 2.20818775 |
| 88 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.19283112 |
| 89 | Gingival bleeding (HP:0000225) | 2.18549048 |
| 90 | Neuronal loss in central nervous system (HP:0002529) | 2.18111578 |
| 91 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.17759624 |
| 92 | Axonal loss (HP:0003447) | 2.17370914 |
| 93 | Pulmonary infiltrates (HP:0002113) | 2.15253365 |
| 94 | Abnormal eating behavior (HP:0100738) | 2.15148497 |
| 95 | Abnormality of glycolysis (HP:0004366) | 2.14138518 |
| 96 | Increased serum pyruvate (HP:0003542) | 2.14138518 |
| 97 | Polyphagia (HP:0002591) | 2.13775552 |
| 98 | Clumsiness (HP:0002312) | 2.12620951 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 2.12176436 |
| 100 | Dysdiadochokinesis (HP:0002075) | 2.10640286 |
| 101 | Exocrine pancreatic insufficiency (HP:0001738) | 2.09872267 |
| 102 | Meningitis (HP:0001287) | 2.09749478 |
| 103 | Tetraplegia (HP:0002445) | 2.08660757 |
| 104 | Autoimmune thrombocytopenia (HP:0001973) | 2.06978461 |
| 105 | Ventricular fibrillation (HP:0001663) | 2.06809039 |
| 106 | Mutism (HP:0002300) | 2.06199629 |
| 107 | Delusions (HP:0000746) | 2.04866486 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 2.04549162 |
| 109 | Paraparesis (HP:0002385) | 2.03916781 |
| 110 | Complement deficiency (HP:0004431) | 2.02991860 |
| 111 | Petechiae (HP:0000967) | 2.02825104 |
| 112 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02139456 |
| 113 | Asymmetric septal hypertrophy (HP:0001670) | 2.02032602 |
| 114 | Basal ganglia calcification (HP:0002135) | 2.01999569 |
| 115 | Gingivitis (HP:0000230) | 2.01765381 |
| 116 | Epileptiform EEG discharges (HP:0011182) | 2.01689668 |
| 117 | Generalized myoclonic seizures (HP:0002123) | 2.00899087 |
| 118 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.00697829 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 2.00541385 |
| 120 | Autoamputation (HP:0001218) | 2.00126442 |
| 121 | Truncal ataxia (HP:0002078) | 2.00010543 |
| 122 | Slow saccadic eye movements (HP:0000514) | 1.99140107 |
| 123 | EEG with generalized epileptiform discharges (HP:0011198) | 1.99089658 |
| 124 | Recurrent fungal infections (HP:0002841) | 1.98875962 |
| 125 | Febrile seizures (HP:0002373) | 1.98343997 |
| 126 | Encephalitis (HP:0002383) | 1.96057226 |
| 127 | Irritability (HP:0000737) | 1.95968753 |
| 128 | Sensory axonal neuropathy (HP:0003390) | 1.95784360 |
| 129 | Pustule (HP:0200039) | 1.95683102 |
| 130 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95601365 |
| 131 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95601365 |
| 132 | Anxiety (HP:0000739) | 1.95416304 |
| 133 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.94673589 |
| 134 | Abnormality of glycine metabolism (HP:0010895) | 1.94673589 |
| 135 | Renal Fanconi syndrome (HP:0001994) | 1.94442144 |
| 136 | J-shaped sella turcica (HP:0002680) | 1.94210979 |
| 137 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93397414 |
| 138 | Purpura (HP:0000979) | 1.93151120 |
| 139 | Clonus (HP:0002169) | 1.92216070 |
| 140 | Methylmalonic aciduria (HP:0012120) | 1.91679182 |
| 141 | Cardiomegaly (HP:0001640) | 1.91401405 |
| 142 | Hypsarrhythmia (HP:0002521) | 1.90819652 |
| 143 | Chronic obstructive pulmonary disease (HP:0006510) | 1.90644514 |
| 144 | Obstructive lung disease (HP:0006536) | 1.90644514 |
| 145 | Confusion (HP:0001289) | 1.90299879 |
| 146 | Thickened helices (HP:0000391) | 1.89938514 |
| 147 | Steatorrhea (HP:0002570) | 1.89889960 |
| 148 | Rigidity (HP:0002063) | 1.89609069 |
| 149 | CNS hypomyelination (HP:0003429) | 1.89177814 |
| 150 | Athetosis (HP:0002305) | 1.88952797 |
| 151 | Flat acetabular roof (HP:0003180) | 1.88739994 |
| 152 | Ileus (HP:0002595) | 1.87986078 |
| 153 | Deep venous thrombosis (HP:0002625) | 1.87084362 |
| 154 | Gastrointestinal infarctions (HP:0005244) | 1.86719964 |
| 155 | Right ventricular cardiomyopathy (HP:0011663) | 1.85878408 |
| 156 | Progressive neurologic deterioration (HP:0002344) | 1.85663758 |
| 157 | Abnormality of complement system (HP:0005339) | 1.84814667 |
| 158 | Broad-based gait (HP:0002136) | 1.84177721 |
| 159 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83008543 |
| 160 | Impaired social interactions (HP:0000735) | 1.82619132 |
| 161 | Abnormal social behavior (HP:0012433) | 1.82619132 |
| 162 | Periodontitis (HP:0000704) | 1.82373788 |
| 163 | Methylmalonic acidemia (HP:0002912) | 1.81847688 |
| 164 | Brittle hair (HP:0002299) | 1.81365969 |
| 165 | Increased circulating renin level (HP:0000848) | 1.80562654 |
| 166 | Septate vagina (HP:0001153) | 1.80468337 |
| 167 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.79123392 |
| 168 | Abnormality of binocular vision (HP:0011514) | 1.78971899 |
| 169 | Diplopia (HP:0000651) | 1.78971899 |
| 170 | Myoclonus (HP:0001336) | 1.78538880 |
| 171 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77925549 |
| 172 | Anteriorly placed anus (HP:0001545) | 1.76790340 |
| 173 | Nasal polyposis (HP:0100582) | 1.74542852 |
| 174 | Poor suck (HP:0002033) | 1.74456068 |
| 175 | Exercise-induced myalgia (HP:0003738) | 1.73845750 |
| 176 | Osteomyelitis (HP:0002754) | 1.73239848 |
| 177 | Abnormality of the lumbar spine (HP:0100712) | 1.73128056 |
| 178 | Tetraparesis (HP:0002273) | 1.71059330 |
| 179 | Hemoptysis (HP:0002105) | 1.70768590 |
| 180 | Hyperactive renin-angiotensin system (HP:0000841) | 1.70661277 |
| 181 | Disinhibition (HP:0000734) | 1.70389227 |
| 182 | Glucose intolerance (HP:0000833) | 1.69441903 |
| 183 | Gastrointestinal stroma tumor (HP:0100723) | 1.69427972 |
| 184 | Abnormality of T cell number (HP:0011839) | 1.68886437 |
| 185 | Amyloidosis (HP:0011034) | 1.67971044 |
| 186 | Keratoconjunctivitis sicca (HP:0001097) | 1.67968823 |
| 187 | Abnormality of the periventricular white matter (HP:0002518) | 1.66546540 |
| 188 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.66333604 |
| 189 | Abnormality of the pleura (HP:0002103) | 1.65808383 |
| 190 | Abnormality of proline metabolism (HP:0010907) | 1.65667994 |
| 191 | Hydroxyprolinuria (HP:0003080) | 1.65667994 |
| 192 | Abnormality of the pericardium (HP:0001697) | 1.65544362 |
| 193 | Abnormality of the nasal mucosa (HP:0000433) | 1.65374609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.14091543 |
| 2 | OXSR1 | 3.39998534 |
| 3 | PNCK | 3.09717106 |
| 4 | ERN1 | 2.93867810 |
| 5 | EPHA2 | 2.81891076 |
| 6 | TYK2 | 2.63803938 |
| 7 | BLK | 2.52324495 |
| 8 | LMTK2 | 2.48853001 |
| 9 | NTRK3 | 2.32114352 |
| 10 | MAP3K9 | 2.31901110 |
| 11 | EPHA4 | 2.24732305 |
| 12 | TESK2 | 2.13575886 |
| 13 | ARAF | 2.08880581 |
| 14 | NTRK1 | 2.03594443 |
| 15 | CDK19 | 2.02970565 |
| 16 | TBK1 | 1.98352774 |
| 17 | MAP2K3 | 1.97011632 |
| 18 | MARK1 | 1.93743762 |
| 19 | MAPKAPK5 | 1.93459364 |
| 20 | WNK4 | 1.89954033 |
| 21 | SCYL2 | 1.88134752 |
| 22 | EPHB1 | 1.78656585 |
| 23 | CAMKK2 | 1.77667990 |
| 24 | NME2 | 1.77316256 |
| 25 | MATK | 1.76660423 |
| 26 | FRK | 1.72554935 |
| 27 | TAOK1 | 1.72147661 |
| 28 | MAP3K14 | 1.70376268 |
| 29 | CAMK2B | 1.63895878 |
| 30 | MAP3K3 | 1.63364845 |
| 31 | WNK1 | 1.60969849 |
| 32 | IRAK4 | 1.58398040 |
| 33 | MAP3K4 | 1.58104374 |
| 34 | MAP3K12 | 1.55208098 |
| 35 | IKBKE | 1.54401036 |
| 36 | KSR2 | 1.53218871 |
| 37 | DAPK2 | 1.51192027 |
| 38 | RIPK4 | 1.48341573 |
| 39 | NME1 | 1.41937629 |
| 40 | BCR | 1.41635753 |
| 41 | PAK6 | 1.41491124 |
| 42 | CAMK2G | 1.40555893 |
| 43 | MAP2K4 | 1.40473812 |
| 44 | MAP3K6 | 1.39954717 |
| 45 | IRAK1 | 1.36776750 |
| 46 | MET | 1.36434125 |
| 47 | JAK1 | 1.34455263 |
| 48 | TRIB3 | 1.33887987 |
| 49 | CAMK2D | 1.32700200 |
| 50 | MAP2K7 | 1.32101103 |
| 51 | SGK223 | 1.31859818 |
| 52 | SGK494 | 1.31859818 |
| 53 | MAP3K2 | 1.31416677 |
| 54 | PKN1 | 1.30835702 |
| 55 | FGFR2 | 1.28467308 |
| 56 | RIPK1 | 1.28139204 |
| 57 | CSF1R | 1.25890459 |
| 58 | ZAP70 | 1.24455629 |
| 59 | FGR | 1.23422625 |
| 60 | EPHA3 | 1.23135300 |
| 61 | CDK5 | 1.15038978 |
| 62 | MAP4K1 | 1.14427664 |
| 63 | MAP3K5 | 1.14305581 |
| 64 | CSK | 1.14125849 |
| 65 | AKT3 | 1.12941582 |
| 66 | TAOK2 | 1.11794821 |
| 67 | MAP3K13 | 1.11400564 |
| 68 | CAMK2A | 1.11329217 |
| 69 | IKBKB | 1.08079502 |
| 70 | CSNK1G2 | 1.07135490 |
| 71 | PRKCG | 1.06410352 |
| 72 | MINK1 | 1.06010764 |
| 73 | FGFR3 | 1.05292101 |
| 74 | ACVR1B | 1.05177991 |
| 75 | CSNK1G3 | 1.05128883 |
| 76 | MAP2K6 | 1.02983748 |
| 77 | BTK | 1.00995441 |
| 78 | MAP3K11 | 0.97595698 |
| 79 | CASK | 0.97561540 |
| 80 | TGFBR2 | 0.95470658 |
| 81 | FES | 0.94382238 |
| 82 | PDPK1 | 0.93468869 |
| 83 | FER | 0.92208138 |
| 84 | GRK5 | 0.91896105 |
| 85 | MAPK11 | 0.91790773 |
| 86 | MAP2K2 | 0.91519551 |
| 87 | NTRK2 | 0.90958277 |
| 88 | TNIK | 0.88610461 |
| 89 | LIMK1 | 0.88500676 |
| 90 | PRKCE | 0.88054647 |
| 91 | ROCK2 | 0.87752151 |
| 92 | CSNK1A1L | 0.87423859 |
| 93 | LATS1 | 0.85382260 |
| 94 | PRKCQ | 0.83236220 |
| 95 | CAMKK1 | 0.82359040 |
| 96 | SYK | 0.81988770 |
| 97 | TRPM7 | 0.81921303 |
| 98 | NEK6 | 0.80917809 |
| 99 | GRK6 | 0.79727079 |
| 100 | CDK14 | 0.79429471 |
| 101 | SIK1 | 0.79170072 |
| 102 | PLK2 | 0.78625562 |
| 103 | JAK2 | 0.78399758 |
| 104 | PRKCH | 0.78292353 |
| 105 | PINK1 | 0.78089688 |
| 106 | PIK3CG | 0.73864704 |
| 107 | ERBB3 | 0.73303206 |
| 108 | FGFR4 | 0.72895222 |
| 109 | PRKD2 | 0.72653364 |
| 110 | JAK3 | 0.72463290 |
| 111 | STK38 | 0.72142171 |
| 112 | CDK15 | 0.71534670 |
| 113 | MARK2 | 0.68395019 |
| 114 | BMPR2 | 0.68171724 |
| 115 | PAK3 | 0.68105093 |
| 116 | MAP2K1 | 0.67932688 |
| 117 | GRK7 | 0.67689876 |
| 118 | BUB1 | 0.67214239 |
| 119 | CDK18 | 0.66610576 |
| 120 | STK11 | 0.66004752 |
| 121 | LYN | 0.65969954 |
| 122 | CSNK1G1 | 0.65790489 |
| 123 | IRAK2 | 0.63712017 |
| 124 | PRKG2 | 0.63353170 |
| 125 | PDK1 | 0.63110207 |
| 126 | KIT | 0.62329600 |
| 127 | CDK11A | 0.61723264 |
| 128 | PRPF4B | 0.61607200 |
| 129 | MST4 | 0.61143233 |
| 130 | PTK2B | 0.59831899 |
| 131 | ERBB4 | 0.59745417 |
| 132 | PTK2 | 0.59341573 |
| 133 | IRAK3 | 0.58107978 |
| 134 | LCK | 0.57747502 |
| 135 | CDC42BPA | 0.57549237 |
| 136 | CSNK1A1 | 0.57425076 |
| 137 | MST1R | 0.56954280 |
| 138 | MARK3 | 0.56187368 |
| 139 | HCK | 0.55130874 |
| 140 | RET | 0.54973505 |
| 141 | UHMK1 | 0.53787525 |
| 142 | PRKAA2 | 0.53654622 |
| 143 | PDK4 | 0.53107463 |
| 144 | PDK3 | 0.53107463 |
| 145 | TXK | 0.52729131 |
| 146 | ICK | 0.52488836 |
| 147 | PIM2 | 0.50838271 |
| 148 | DYRK1A | 0.49943205 |
| 149 | SIK3 | 0.48745864 |
| 150 | PRKCZ | 0.48110464 |
| 151 | MAP3K1 | 0.46785444 |
| 152 | CHUK | 0.44984686 |
| 153 | INSRR | 0.44756859 |
| 154 | BRAF | 0.43418055 |
| 155 | WNK3 | 0.42812154 |
| 156 | TAOK3 | 0.42413203 |
| 157 | FYN | 0.42084371 |
| 158 | CCNB1 | 0.42007958 |
| 159 | TYRO3 | 0.41172572 |
| 160 | MAPK13 | 0.40744533 |
| 161 | SIK2 | 0.40170334 |
| 162 | PRKACA | 0.40084252 |
| 163 | PRKCA | 0.39849777 |
| 164 | PDK2 | 0.39647774 |
| 165 | MAPK12 | 0.39158028 |
| 166 | YES1 | 0.36131754 |
| 167 | NEK9 | 0.35879478 |
| 168 | PDGFRB | 0.35122654 |
| 169 | OBSCN | 0.33740364 |
| 170 | PIK3CA | 0.33672422 |
| 171 | TNK2 | 0.30692215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.88404399 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.67970350 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65545805 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.59856455 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.53888399 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.51444375 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.48425114 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.44349412 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.42873966 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.30086188 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.29541212 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.28197945 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.25067422 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.23630781 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22613112 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.22330302 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.17635522 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14778619 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11686125 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11503207 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 2.08001886 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92296389 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83347332 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.74786811 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70135439 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68736311 |
| 27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.67506849 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.67321366 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64192795 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.59708229 |
| 31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.59559700 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.57740562 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55096953 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.52903086 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.50240264 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.48887362 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 1.44591333 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43789408 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43099163 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42847515 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42782677 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.42690900 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41325987 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40814786 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.37173449 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36664690 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.30538454 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29798306 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29335047 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 1.28377638 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 1.27286002 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 1.26266939 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 1.23806551 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23582378 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.20509898 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19654826 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17977517 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17155200 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16183393 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15702963 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.13521372 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12362836 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12333164 |
| 64 | Taste transduction_Homo sapiens_hsa04742 | 1.11292491 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 1.10334653 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.07861562 |
| 67 | Measles_Homo sapiens_hsa05162 | 1.07793394 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06839824 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.06794867 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 1.06630354 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06414316 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 1.06352173 |
| 73 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.05500188 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04871574 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04774956 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03194649 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 1.02776855 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 1.02433353 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.01538967 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 1.01367257 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00922511 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.00770843 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99410364 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98355339 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.96652246 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95471469 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95101828 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94454020 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.93451762 |
| 90 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93256917 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91873578 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88175405 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86102898 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85968724 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84797367 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.83158991 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82838044 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82309104 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81379080 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80268990 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.77764972 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.76955693 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75276488 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74830578 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.74742225 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73352197 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73286516 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72651731 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71274414 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.71267318 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71242921 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71087431 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70651388 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.70124745 |
| 115 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70065115 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69678661 |
| 117 | Apoptosis_Homo sapiens_hsa04210 | 0.69280175 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68811970 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68508481 |
| 120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67924006 |
| 121 | Malaria_Homo sapiens_hsa05144 | 0.67467635 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66989909 |
| 123 | Protein export_Homo sapiens_hsa03060 | 0.66642799 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66596487 |
| 125 | Renin secretion_Homo sapiens_hsa04924 | 0.66398697 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66278150 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65637458 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64459485 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64314984 |
| 130 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64131098 |
| 131 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63331411 |
| 132 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62478728 |
| 133 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61953624 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61687189 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61182156 |
| 136 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60644810 |
| 137 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60473251 |
| 138 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59100359 |
| 139 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58272653 |
| 140 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57877882 |
| 141 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57398070 |
| 142 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57169727 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.57041331 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56309421 |
| 145 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56295217 |
| 146 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55791438 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55762841 |
| 148 | Platelet activation_Homo sapiens_hsa04611 | 0.55560367 |
| 149 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55538630 |
| 150 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55382773 |
| 151 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55297253 |
| 152 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54188796 |
| 153 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53844114 |
| 154 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53840775 |
| 155 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53536804 |
| 156 | Endocytosis_Homo sapiens_hsa04144 | 0.52972648 |
| 157 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52961337 |
| 158 | Prion diseases_Homo sapiens_hsa05020 | 0.52021471 |
| 159 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51611214 |
| 160 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51567665 |
| 161 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49923480 |
| 162 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49693206 |
| 163 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48977864 |
| 164 | Proteasome_Homo sapiens_hsa03050 | 0.48325456 |
| 165 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46911101 |
| 166 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46304193 |
| 167 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45825993 |
| 168 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45733573 |
| 169 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45351395 |
| 170 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45023340 |
| 171 | Gap junction_Homo sapiens_hsa04540 | 0.44931766 |
| 172 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44765723 |
| 173 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44370062 |
| 174 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44178910 |
| 175 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44045156 |
| 176 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43582190 |
| 177 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42772929 |
| 178 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42500687 |
| 179 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40209109 |
| 180 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40068768 |

